Adaptation of the P1 phage-derived Cre/loxP sitespecific recombination system to the gene targeting technique allows for the conditional deletion of genes in mice. To selectively modify genes in B lymphocytes, we have generated mice (designated CD19-Cre) which express cre under the transcriptional control of the B lineage-restricted CD19 gene. In a model system involving the cross of CD19-Cre mice with mice bearing a loxP-flanked substrate, we find a deletion efficiency of 75-80% in bone marrow-derived pre-B cells that increases to 90-95% in splenic B cells.
The gene targeting technique permits the introduction of defined mutations into the mouse germline and has greatly enhanced and expanded genetic approaches to examine gene function in vivo (1, 2) . Generally, this approach is used to inactivate an allele by homologous recombination in embryonic stem (ES) cells, followed by the derivation of mutant mouse lines through the generation of chimeric mice and subsequent breeding of mice bearing the transmitted mutant allele. Such gene ablation experiments are now near standard protocol as a means to understand the physiological role of a given gene product. Nonetheless, there are certain limitations in both the interpretation and application of congenital gene inactivation studies. This stems from the fact that the loss of a gene early in development often results in embryonic lethality or developmental compensation. Although informative, such results may preclude investigation of the intended biological problem.
Recently, the Cre/loxP recombination system of bacteriophage P1 (3, 4) has been adapted to function in ES cells and shown to be a powerful system to mediate both subtle (5, 6 ) and large scale mutations (7) . This is made possible by the targeted insertion of recognition sites, termed loxP, at defined sites in the mouse genome. In the presence of Cre, the intervening DNA segment flanked by loxP sites ('floxed') is either deleted or inverted, depending upon the orientation of the loxP sites. This is the basis for the recent application of this system for the 'conditional' inactivation of genes (or activation of genes by removal of inhibitory sequences) in mice (8) , which is achieved by the inducible (9) or cell type-specific (10-13) expression of cre and subsequent deletion of the floxed, but functional, gene segment. The option to generate germline mutations remains, particularly with the availability of transgenic mice that can introduce Cre-mediated modifications into the germline (14, 15) .
Here we report the creation of a system for genetic manipulation of cells of the B lineage in mice by expression of cre under the transcriptional control of the CD19 promoter. CD19 was chosen since it is only transcribed in cells of the B lineage (16) . Moreover, CD19 is expressed at the earliest stages and throughout B cell development and differentiation (17) . To obtain CD19-directed cre expression, a cre expression cassette was inserted into the second exon of CD19 by homologous recombination in ES cells (18; Fig. 1 ). Thus, all the regulatory elements of the endogenous CD19 locus are present, whereas the addition of a heterologous β-globin intron and polyadenylation site was introduced to ensure appropriate splicing and polyadenylation of the cre RNA. Insertion of cre disrupts the CD19 coding sequence, leading to a CD19 deficiency in the homozygous situation (18) . Mice hemizygous for the cre insertion (designated CD19-Cre mice) which retain one functional CD19 allele are phenotypically normal and can be used for B lineage specific deletion of a floxed target gene.
To determine the efficiency and specificity of Cre-mediated deletion in B cells, CD19-Cre mice were crossed with mice bearing a DNA polymerase β gene (polβ) in a wild-type (polβ WT ), floxed (polβ flox ) or deleted (polβ ∆ ) germline configuration (12) . Recombination of the introduced loxP sites excises the promoter and first exon of polβ, rendering the allele inactive (Fig.  2) . Hence, somatic deletion of polβ can be monitored by Southern blot analysis of genomic DNA purified from the target cell population, and quantitation of the loss of the polβ flox allele and acquisition of the polβ ∆ allele. In splenic B cells we consistently find a deletion efficiency of 90-95%, irrespective of whether the genotype of the mice is polβ flox /polβ WT or polβ flox /polβ ∆ (Fig. 2) . This result, and the presence of B cells in normal numbers in these mice (data not shown), suggest that pol β-deficient B cells are not significantly disadvantaged, despite the essential role of this repair enzyme during embryogenesis (11) . Deletion was only evident in cells of the B lineage, since the polβ locus in T cells and cells from non-lymphoid tissues (liver, brain, intestine, kidney and lung) was maintained in germline configuration (Fig. 2 and  data not shown) . To determine the degree of deletion in developing B cells, DNA was prepared from bone marrow pre-B cells. Here the deletion efficiency of 75-80% is lower than in mature splenic B cells, indicating that Cre-mediated deletion is an ongoing process during B cell development. This is consistent with the known expression pattern of CD19, and correlates well with Cre expression in CD19-Cre mice as revealed through staining with Cre-specific antibodies (21) .
The blastocyst complementation system using severe combined immunodeficiency (SCID, 19) mice or recombination-activating Targeting of the CD19 locus has been described in detail elsewhere (18) . In brief, the cre gene was modified using a PCR based method as described (5), whereby a eukaryotic translation initiation consensus sequence and the nuclear localization signal of the SV40 large T antigen were introduced into the cre gene at the 5′-end using the following 5′ and 3′ primers, respectively: TTAGTCGACCATGCCCAAGAAGAAGAGGAAGGTGTC-CAATTTACTGAC and CTGAAGATATAGAAGAT. An 1180 bp fragment containing the rabbit β-globin intron (Stratagene, La Jolla, CA, USA) was inserted at the 3′-end of the cre gene followed by the neomycin resistance gene flanked by FRT sites (22) . Although deletion of the FRT-flanked neo r gene (18) by the Flp recombinase may be desirable, it appears that its presence does not have an appreciable effect on cre expression. gene (RAG)-deficient mice (20) provides a means to study the effect of targeted mutations specifically in the lymphoid compartment. SCID or RAG blastocyst-derived B and T lineage cells are blocked at an early stage of development due to the inability to rearrange their immunoglobulin and T cell receptor gene segments. Thus, in chimeric mice generated by injection of manipulated ES cells the only mature B or T cells present should be ES cell derived. Although this system provides for rapid phenotypic analyses by avoiding time consuming breeding of homozygous mutant mice, it is laborious in that homozygous mutant ES cells need to be generated in vitro, and blastocyst injection is an ongoing necessity to produce chimeric animals for analysis. Moreover, the variable degree of chimerism is a parameter difficult to control, and blastocyst-derived normal lymphoid progenitors may out compete ES-derived mutant cells.
In the context of the Cre/loxP system, the CD19-Cre mice offer an alternative to the RAG/SCID complementation systems, allowing for conditional deletion in B cells but leaving T cells unaffected. The fact that the efficiency of Cre-mediated deletion in CD19-Cre mice is not complete may be a factor of concern because 'wild-type' cells which escape Cre activity may selectively expand. Functionally 'neutral' floxed substrates or the deletion of heterozygous floxed alleles allow to evaluate the principal efficiency of cre-mediated deletion under non-selecting conditions. The comparison of the latter with deletion resulting in the complete absence of a gene would be informative as to the role of the gene in a given biological context, as we have shown here for polβ. As it is likely that the efficiency of Cre-mediated recombination in vivo will vary with respect to the floxed substrate and the source of Cre expression, a challenge for the future is to devise a means to introduce an indicator gene into the target gene in such a way that cells which have undergone a deletion event could be identified directly. . The percent deletion (mean ± SD) was calculated as described (9) and normalized for the purity of the sorted population, which was always >95%. 
